Experts are still encouraging people to take the drug if prescribed. When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the ...

Just over one in five people who take the covid-19 drug Paxlovid may be contagious after coming off the treatment, but doctors say this isn’t a reason to stop prescribing it. In a recent study, people ...

Please provide your email address to receive an email when new articles are posted on . Paxlovid and other antiviral treatments do not increase risk for COVID-19 rebound. Studies show rebound risk is ...

COVID-19 has become less of an urgent threat than it was in 2019 largely because of vaccines and growing immunity from natural infections, but antiviral treatments have also changed the course of the ...

As the coronavirus evolves, the number of treatment options that remain effective against new variants has dwindled. Pfizer's antiviral pill Paxlovid is one of the few that remain. However, some ...

People who have a Covid-19 rebound after treatment with the antiviral drug Paxlovid can be contagious and may not know it because they might not have symptoms, researchers warn. People who have a ...

Please provide your email address to receive an email when new articles are posted on . Two separate analyses of studies and trials suggest that COVID-19 rebound is not linked to Paxlovid or other ...

SAN FRANCISCO -- The popular COVID treatment, Paxlovid, does not significantly lower the risk of "long COVID" for people who are vaccinated. In a new study from UCSF, researchers found that patients ...

A study involving more than 12,000 COVID-19 patients in Hong Kong found the incidence of viral rebound was very low. For the study, published Dec. 6 in JAMA Network Open, researchers at the Chinese ...

COVID rebound is when COVID-19 symptoms return soon after they go away or a person registers a positive COVID-19 test result after testing negative for several days. COVID rebound can happen in people ...

After COVID-19 NPIs lifted, respiratory infections reverted toward pre pandemic seasonality, with winter peaks for RSV and ...